Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes

NCT02268214 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

833

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: Dapagliflozin
DRUG: Placebo for dapagliflozin

Sponsor

AstraZeneca

Collaborators

[object Object]